antitrust

Gilead Sciences, after trial win, moves ahead with $247M settlement in HIV antitrust case
Gilead Sciences, after trial win, moves ahead with $247M settlement in HIV antitrust case
Fierce Pharma
Gilead Sciences
Teva Pharmaceutical
HIV
legal
antitrust
Flag link:
Takeda settles antitrust lawsuit over gout drug Colcrys after trial kicked off
Takeda settles antitrust lawsuit over gout drug Colcrys after trial kicked off
Fierce Pharma
Takeda
generics
gout
Colcrys
antitrust
Flag link:
Amgen-Horizon Merger Clearance a Setback to FTC’s Antitrust Enforcement Plans
Amgen-Horizon Merger Clearance a Setback to FTC’s Antitrust Enforcement Plans
BioSpace
Amgen
Horizon Therapeutics
FTC
antitrust
M&A
Flag link:
New antitrust merger guidelines could have chilling effect on healthcare deals
New antitrust merger guidelines could have chilling effect on healthcare deals
BioPharma Dive
antitrust
FTC
M&A
Flag link:
FTC Scrutiny Chills Medtech M&A Market
FTC Scrutiny Chills Medtech M&A Market
Medical Devices and Diagnostics Industry
Medtech
M&A
FTC
antitrust
Flag link:
FTC proposes updates to merger review that could slow healthcare dealmaking
FTC proposes updates to merger review that could slow healthcare dealmaking
BioPharma Dive
FTC
M&A
antitrust
Flag link:
Gilead, Teva reach 11th-hour settlements with some groups in HIV antitrust case
Gilead, Teva reach 11th-hour settlements with some groups in HIV antitrust case
Fierce Pharma
Gilead Sciences
Teva Pharmaceutical
HIV
legal
antitrust
Flag link:
After years of litigation, Gilead and Teva's HIV antitrust trial kicks off in California
After years of litigation, Gilead and Teva's HIV antitrust trial kicks off in California
Fierce Pharma
Gilead Sciences
Teva Pharmaceutical
legal
HIV
antitrust
Flag link:
Regeneron CEO backs FTC’s attempt to block $28B Amgen-Horizon deal
Regeneron CEO backs FTC’s attempt to block $28B Amgen-Horizon deal
Medical Marketing and Media
Amgen
Horizon Therapeutics
FTC
Regeneron
antitrust
M&A
Leonard Schleifer
Flag link:
Does FTC attempt to block Amgen's Horizon buy spell trouble for Pfizer-Seagen? Not necessarily, analysts say
Does FTC attempt to block Amgen's Horizon buy spell trouble for Pfizer-Seagen? Not necessarily, analysts say
Fierce Pharma
FTC
M&A
Amgen
Horizon Therapeutics
Pfizer
Seagen
antitrust
Flag link:
Heightened US antitrust fears rattle biopharma
Heightened US antitrust fears rattle biopharma
EP Vantage
M&A
antitrust
Amgen
Astellas
Bellus Health
Globus Medical
GSK
Horizon Therapeutics
Merck
NuVasive
Pfizer
Prometheus Biosciences
Seagen
Flag link:
Pfizer, Seagen kick off antitrust review of $43B merger. Will FTC get on board?
Pfizer, Seagen kick off antitrust review of $43B merger. Will FTC get on board?
Fierce Pharma
Pfizer
Seagen
M&A
antitrust
DOJ
FTC
Flag link:
In Zetia antitrust case, Merck and Glenmark ink deals with 2 plaintiff groups as retailers hold out
In Zetia antitrust case, Merck and Glenmark ink deals with 2 plaintiff groups as retailers hold out
Fierce Pharma
Merck
Glenmark
Zetia
pay-for-delay
antitrust
legal
Flag link:
Sanofi's Provention buyout hit with FTC delay. Will Pfizer's Seagen deal go off as planned?
Sanofi's Provention buyout hit with FTC delay. Will Pfizer's Seagen deal go off as planned?
Fierce Pharma
M&A
antitrust
FTC
Sanofi
Provention Bio
Pfizer
Seagen
Flag link:
Viatris maintains legal winning streak with yet another EpiPen antitrust victory
Viatris maintains legal winning streak with yet another EpiPen antitrust victory
Fierce Pharma
Viatris
EpiPen
Mylan
legal
antitrust
Flag link:
J&J finalizes $25M settlement, laying Remicade antitrust allegations to rest
J&J finalizes $25M settlement, laying Remicade antitrust allegations to rest
Endpoints
JNJ
legal
Remicade
antitrust
biosimilars
Flag link:
In Pfizer-Seagen review, FTC has chance to set new pharma precedent
In Pfizer-Seagen review, FTC has chance to set new pharma precedent
BioPharma Dive
FTC
Pfizer
Seagen
M&A
antitrust
anticompetitive practices
Flag link:
In antitrust suit, Hikma says Amarin locked up exclusive supply deals to shut out Vascepa generics
In antitrust suit, Hikma says Amarin locked up exclusive supply deals to shut out Vascepa generics
Fierce Pharma
Amarin
Hikma
legal
antitrust
generics
Vascepa
Flag link:
Gilead, Teva and J&J's HIV antitrust case inches closer to trial as judge keeps most claims on the table
Gilead, Teva and J&J's HIV antitrust case inches closer to trial as judge keeps most claims on the table
Fierce Pharma
Gilead Sciences
legal
HIV
antitrust
Teva Pharmaceutical
JNJ
Flag link:
Novartis, Roche avoid $475M antitrust fine in French appeals court
Novartis, Roche avoid $475M antitrust fine in French appeals court
Fierce Pharma
Novartis
Roche
antitrust
Lucentis
Flag link:

Pages